Transient Increase Seen in CV Events Following Gout Flare

MONDAY, Aug. 8, 2022 (HealthDay News) -- Gout flares seem to be associated with a transient increase in the risk for cardiovascular events, according to a study published in the Aug. 2 issue of the Journal of the American Medical Association.
Edoardo Cipolletta, M.D., from the University of Nottingham in the United Kingdom, and colleagues conducted a retrospective observational study to examine whether there is a transient increase in the risk for cardiovascular events after a recent gout flare. A nested case-control study was performed among 62,574 patients with gout, and a self-controlled case series was conducted among 1,421 patients with gout flare and a cardiovascular event.
The researchers found that compared with the 52,099 patients from the nested case-control study without cardiovascular events, the 10,475 patients with cardiovascular events had significantly higher odds of gout flare within the previous 0 to 60 and 61 to 120 days; no significant difference was seen in the odds of gout flare within the previous 121 to 180 days. In the self-controlled case series, cardiovascular event rates were 2.49, 2.16, and 1.70 per 1,000 person-days within 0 to 60, 61 to 120, and 121 to 180 days after a gout flare, respectively, compared with cardiovascular event rates of 1.32 per 1,000 person-days within 150 days before or 181 to 540 days after a gout flare.
"The findings of the study by Cipolletta et al should alert clinicians and patients to the increased cardiovascular risk in the weeks beginning after a gout flare and should focus attention on optimizing preventive measures," write the authors of an accompanying editorial.
One author disclosed financial ties to the biopharmaceutical and medical technology industries.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
How the COVID Virus Sneaks Past Immune Defenses
TUESDAY, Dec. 28, 2021 (HealthDay News) – Just how SARS-CoV-2 eludes the human...
FDA Gives Full Approval to Alzheimer’s Drug Leqembi
THURSDAY, July 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...
Dangerous Myths Keep Many Adults With Food Allergies From Getting an EpiPen
MONDAY, Nov. 14, 2022 (HealthDay News) -- The EpiPen is a known lifesaver when...
Los ‘abuelos activos’: los humanos evolucionaron para hacer ejercicio en la vejez
MARTES, 23 de noviembre de 2021 (HealthDay News) -- Convertirse en sedentario a...